LYTIR

Company · KRYS

Krystal Biotech, Inc.

Nasdaq's symbol directory lists KRYS on Nasdaq as “Krystal Biotech, Inc. - Common Stock”.

In the 12 months to Nov 8, 2026: insiders sold on 4 occasions ($26.5M); 2 filings by holders of 5% or more; 2 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC · Appeared in No. 38

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $26.5M in total.Jun: Insider sales $347KAug: Insider sales $8.2MSep: Insider sales $18.0MDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $26.5M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Krish S. Krishnan, President and CEO sold on 1 day all under a 10b5-1 plan latest Sep 4, 2026 sold $9.0M
  2. Krishnan Suma, President, R&D sold on 1 day all under a 10b5-1 plan latest Sep 4, 2026 sold $9.0M
  3. Dino A. Rossi sold on 1 day latest Aug 14, 2026 sold $8.2M
  4. Thomas John Charles, EVP, General Counsel sold on 1 day all under a 10b5-1 plan latest Jun 25, 2026 sold $347K
Every trade (4)
  1. SELLKrish S. Krishnan, President and CEO sold Sep 4, 2026 25,000 shares 13 legs combined 10b5-1 plan (scheduled) filing $9.0M
  2. SELLKrishnan Suma, President, R&D sold Sep 4, 2026 25,000 shares 13 legs combined 10b5-1 plan (scheduled) filing $9.0M
  3. SELLDino A. Rossi sold Aug 14, 2026 25,000 shares 8 legs combined filing $8.2M
  4. SELLThomas John Charles, EVP, General Counsel sold Jun 25, 2026 1,000 shares 10b5-1 plan (scheduled) filing $347K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. Vanguard Portfolio Management filed Oct 30, 2026 Schedule 13G/A passive 1,312,431 shares filing 4.43%
  2. BlackRock, Inc. filed Oct 27, 2026 Schedule 13G/A passive 3,427,645 shares filing 11.6%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition filing Nov 2, 2026
  2. Regulation FD disclosure filing Oct 15, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.